Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In a Phase 2 substudy published in Nature Medicine (June 2024), the 12mg dose reduced liver fat by 82.4% at 24 weeks
As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients
Decades of scientific analysis and discovery, backed by a dedication to technical and sales support, have established an environment that drives consumer awareness and usage today
Data Availability The data that support the findings of this study are available from the corresponding author upon reasonable request
